Replies to post #160657 on Biotech Values

[DewDiligence]

GILD—from interim results [of phase-2 LONESTAR study] it seems that 8 weeks DAA regimen could work for GT1 naïve...

The question to ask is whether 8 weeks of an all-oral regimen including ribavirin is preferable from a patient's perspective to 12 weeks of the same all-oral regimen without ribavirin.

[DewDiligence]

Interim-data table from GILD’s phase-2 LONESTAR study:



Ledipasvir is GS-5885 (an NS5A inhibitor).